Archives
FDA Advisory Panel Will Assess Avandia Safety in June
The Food and Drug Administration will hold a meeting in June to reassess the safety of GlaxoSmithKline's former blockbuster diabetes drug Avandia almost three years after they curbed its sales over cardiovascular risks.
Latest Research Articles
Climate Change Not To Blame For 2012 Drought, Say Government Scientists
Spot Jupiter In The Daylight Sunday With Help From The Moon
Hawaiian Officials Okay Plans To Build 30-Meter, $1.3 Billion Telescope Atop Mauna Kea
Beijing Reports First Known Case of Avian Flu Virus H7N9
Powerful Earthquake Jolts Japan, No Damage To Nuclear Facilities Reported
Artic Summer Ice Nearing End, Say Climate Change Scientists
Russia To Spend $52 Billion On Space Exploration, Eyes Moon Base In 2030
New HIV/AIDS Drug In South Africa Streamlines Treatment And Lowers Costs
Texas Congressman Points To Noah's Flood To Prove Climate Change Is Not Man-Made [VIDEO]
Astronaut Chris Hadfield's Photos From Space Are Out-Of-This-World Good [VIDEO]
Scientists Observe A Change In Season's On Moon Titan For First Time
Man Dead In Belarus After Rare Beaver Attack [VIDEO]
MOST POPULAR
-
Sunken Worlds in Earth's Mantle: High-Res Models Challenge Current Theories
-
With No Water Coming Out of Fire Hydrants, Can Ocean Water Be Used to Fight Raging LA Fire?
-
Young Boy's Ant Discovery Uncovers Hidden Connection in Nature
-
Weak Spot in Earth's Magnetic Field Raises Concerns for Humanity's Future
-
Northern Lights Could Grace the US Skies Tonight – Here’s Where to Look
